Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics

International Journal of Environmental Research and Public Health

Volumn 8, Issue 7, 2011, Pages 2816-2827

  Maremmani, Angelo Giovanni Icro ^a,b   Pani, Pier Paolo ^c   Rovai, Luca ^a   Pacini, Matteo ^d   Dell'Osso, Liliana ^a   Maremmani, Icro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b From Science to Public Policy Association   (Italy)

^c Territorial Department of Nephrology and Dialysis   (Italy)

^d G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

Author keywords

Alcohol dependence; GHB disulfiram combination; Long term treatment

Indexed keywords

4 HYDROXYBUTYRIC ACID; DISULFIRAM;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CHRONIC DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EDUCATION; EMPLOYMENT STATUS; FEMALE; HUMAN; INCOME; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL DISEASE; SOCIAL ADAPTATION; TREATMENT DURATION; TREATMENT RESPONSE; UNEMPLOYMENT; WITHDRAWAL SYNDROME;

EID: 79960747632     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8072816     Document Type: Article

References (48)

1. Addolorato, G.; Armuzzi, A.; Gasbarrini, G.; De Lorenzi, G.; Ancona, C.; Abenavoli, L.; Parente, A.; Leggio, L.; Capristo, E.; Greco, A.V.; Janiri, L.; Pozzi, G.; Taranto, C.; Caputo, F.; Bernardi, M.; Stefanini, G. F.; Foschi, F. G., Pharmacological approaches to the management of alcohol addiction. Eur. Rev. Med. Pharmacol. Sci. 2002, 6, 89-97.
2. Olive, M.F. Pharmacotherapies for alcoholism: The old and the new. CNS Neurol. Disord. Drug Targets 2010, 9, 2-4.
3. West, S.L.; Garbutt, J.C.; Carey, T.S.; Lux, L.J.; Jackman, A.M.; Tolleson-Rinehart, S.; Lohr, K.N.; Crews, F.T. Pharmacotherapy for alcohol dependence. Evid. Rep./Technol. Assess. (Summ) 1999, 3, 1-5.
4. Rosner, S.; Hackl-Herrwerth, A.; Leucht, S.; Vecchi, S.; Srisurapanont, M.; Soyka, M. Opioid antagonists for alcohol dependence. Cochrane Database Syst. Rev. 2010, 12, CD001867.
5. Srisurapanont, M.; Jarusuraisin, N. Opioid antagonists for alcohol dependence. Cochrane Database Syst. Rev. 2005, 1, CD001867.
6. Srisurapanont, M.; Jarusuraisin, N. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int. J. Neuropsychopharmacol. 2005, 8, 267-80.
7. Lukasik, K.; Piatkowska, K.; Pietrzak, B. The role of the glutamatergic system in the pathogenesis and treatment of alcohol dependence. Postepy Hig. Med. Dosw. (Online) 2010, 64, 534-43.
8. Mason, B.J. Treatment of alcohol-dependent outpatients with acamprosate: A clinical review. J. Clin Psychiatry 2001, 62, 42-48.
9. Caputo, F.; Bernardi, M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr. Pharm. Des. 2010, 16, 2118-2125.
10. Beghe, F.; Carpanini, M.T. Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients. Alcohol 2000, 20, 223-225.
11. Sewell, R.A.; Petrakis, I.L. Does gamma-hydroxybutyrate (GHB) have a role in the treatment of alcoholism? Alcohol Alcohol. 2011, 46, 1-2.
12. Caputo, F.; Stoppo, M.; Vignoli, T.; Francini, S.; Lorenzini, F.; Bernardi, M. Use of alcohol during the treatment of alcohol dependence with gamma-hydroxybutyric acid: Risk of severe events are avoided by the dose fractioning of the drug. J. Clin. Psychopharmacol. 2007, 27, 418.
13. Caputo, F.; Bernardi, M. Treatment of alcohol dependence with gamma hydroxybutyric acid. Acta Neurol. Scand. 2007, 115, 368; author reply 369-370.
14. Maremmani, I.; Lamanna, F.; Tagliamonte, A. Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics. J. Psychoactive Drugs 2001, 33, 135-142.
15. Addolorato, G.; Cibin, M.; Caputo, F.; Capristo, E.; Gessa, G.L.; Stefanini, G.F.; Gasbarrini, G. Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients. Drug Alcohol Depend. 1998, 53, 7-10.
16. Addolorato, G.; Castelli, E.; Stefanini, G.F.; Casella, G.; Caputo, F.; Marsigli, L.; Bernardi, M.; Gasbarrini, G. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol Alcohol. 1996, 31, 341-345.
17. Gallimberti, L.; Ferri, M.; Ferrara, S.D.; Fadda, F.; Gessa, G.L. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: A double-blind study. Alcohol. Clin. Exp. Res. 1992, 16, 673-676.
18. Leone, M.A.; Vigna-Taglianti, F.; Avanzi, G.; Brambilla, R.; Faggiano, F. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst. Rev. 2010, 2, CD006266.
19. Ferrara, S.D.; Zotti, S.; Tedeschi, L.; Frison, G.; Castagna, F.; Gallimberti, L.; Gessa, G.L.; Palatini, P. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol. 1992, 34, 231-235.
20. Maremmani, I.; Balestri, C.; Lamanna, F.; Tagliamonte, A. Efficacy of Split Doses of GHB Used as Anticraving in the Treatment of Alcohol Dependence. Preliminary Results. Alcoholism 1998, 34, 73-80.
21. Caputo, F.; Francini, S.; Stoppo, M.; Lorenzini, F.; Vignoli, T.; Del Re, A.; Comaschi, C.; Leggio, L.; Addolorato, G.; Zoli, G.; Bernardi, M. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study. J. Psychopharmacol. 2009, 23, 883-890.
22. Suh, J.J.; Pettinati, H.M.; Kampman, K.M.; O'Brien, C.P. The status of disulfiram: A half of a century later. J. Clin. Psychopharmacol. 2006, 26, 290-302.
23. Grover, S.; Bhateja, G.; Basu, D. Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology. Indian J. Psychiatry 2007, 49, 19-25.
24. Williams, S.H. Medications for treating alcohol dependence. Am. Fam. Physician 2005, 72, 1775-1780.
25. Fonsi Elbreder, M.; de Souza e Silva, R.; Pillon, S.C.; Laranjeira, R. Alcohol dependence: Analysis of factors associated with retention of patients in outpatient treatment. Alcohol Alcohol. 2011, 46, 74-76.
26. Elbreder, M.F.; de Humerez, D.C.; Laranjeira, R. The use of disulfiram for alcohol-dependent patients and duration of outpatient treatment. Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260, 191-195.
27. Laaksonen, E.; Koski-Jannes, A.; Salaspuro, M.; Ahtinen, H.; Alho, H. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol. 2008, 43, 53-61.
28. Mueser, K.T.; Noordsy, D.L.; Fox, L.; Wolfe, R. Disulfiram treatment for alcoholism in severe mental illness. Am. J. Addict. 2003, 12, 242-252.
29. Fuller, R.K.; Gordis, E. Does disulfiram have a role in alcoholism treatment today? Addiction 2004, 99, 21-24.
30. Krampe, H.; Ehrenreich, H. Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr. Pharm. Des. 2010, 16, 2076-2090.
31. Niederhofer, H.; Staffen, W. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev. 2003, 22, 295-297.
32. Mutschler, J.; Diehl, A.; Vollmert, C.; Herre, H.; Mann, K.; Kiefer, F. Recent results in relaps prevention of alcoholism with Disulfiram. Neuropsychiatry 2008, 22, 243-251.
33. Mutschler, J.; Diehl, A.; Kiefer, F. Pharmacology of disulfiram-an update. Fortschr Neurol Psychiatr 2008, 76, 225-231.
34. Pacini, M.; Maremmani, A.G.I.; Rovai, L.; Rugani, F.; Maremmani, I. Treating heroin addicts. Blocking dosages and stimulation-stabilization of opioidergic system. Heroin Addict. Relat. Clin. Probl. 2010, 12, 41-48.
35. Dole, V.P.; Nyswander, M.E.; Kreek, M.J. Narcotic Blockade. Arch. Intern. Med. 1966, 118, 304-309.
36. American Psichiatric Association. DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders; APA: Washington, DC, USA, 2000.
37. Guy, W. ECDEU Assessment Manual for Psychopharmacology. Clinical Global Impressions; U.S. Department of Health, Education, and Welfare: Rockville, MD, USA, 1976; p 218-222.
38. Lettieri, J.T.; Fung, H.L. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J. Pharmacol. Exp. Ther. 1979, 208, 7-11.
39. Bourdelat-Parks, B.N.; Anderson, G.M.; Donaldson, Z.R.; Weiss, J.M.; Bonsall, R.W.; Emery, M.S.; Liles, L.C.; Weinshenker, D. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology (Berl) 2005, 183, 72-80.
40. Haile, C.N.; During, M.J.; Jatlow, P.I.; Kosten, T.R.; Kosten, T.A. Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats. Biol. Psychiatry 2003, 54, 915-921.
41. Petrakis, I.L.; Carroll, K.M.; Nich, C.; Gordon, L.T.; McCance-Katz, E.F.; Frankforter, T.; Rounsaville, B.J. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 2000, 95, 219-228.
42. Schank, J.R.; Ventura, R.; Puglisi-Allegra, S.; Alcaro, A.; Cole, C.D.; Liles, L. C.; Seeman, P.; Weinshenker, D. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Neuropsychopharmacology 2006, 31, 2221-2230.
43. Kim, A.K.; Souza-Formigoni, M.L. Disulfiram impairs the development of behavioural sensitization to the stimulant effect of ethanol. Behav. Brain Res. 2010, 207, 441-446.
44. Lategan, A.J.; Marien, M.R.; Colpaert, F.C. Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res. 1990, 523, 134-138.
45. Grenhoff, J.; Nisell, M.; Ferre, S.; Aston-Jones, G.; Svensson, T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural. Transm. Gen. Sect. 1993, 93, 11-25.
46. Gaval-Cruz, M.; Weinshenker, D. Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol. Interv. 2009, 9, 175-187.
47. Schroeder, J.P.; Cooper, D.A.; Schank, J.R.; Lyle, M.A.; Gaval-Cruz, M.; Ogbonmwan, Y.E.; Pozdeyev, N.; Freeman, K.G.; Iuvone, P.M.; Edwards, G.L.; Holmes, P.V.; Weinshenker, D. Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase. Neuropsychopharmacology 2010, 35, 2440-2449.
48. Caputo, F.; Addolorato, G.; Stoppo, M.; Francini, S.; Vignoli, T.; Lorenzini, F.; Del Re, A.; Comaschi, C.; Andreone, P.; Trevisani, F.; Bernardi, M. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study. Eur. Neuropsychopharmacol. 2007, 17, 781-789.